---------- Forwarded message ----------
From: sadhan roychowdhury <sadhan.roychowdhury1@gmail.com>
Date: Thu, Jun 16, 2011 at 1:43 PM
Subject: Fwd: FW: Blood Cancer
--
From: sadhan roychowdhury <sadhan.roychowdhury1@gmail.com>
Date: Thu, Jun 16, 2011 at 1:43 PM
Subject: Fwd: FW: Blood Cancer
---------- Forwarded message ----------
From: Rabin Chakraborty <rabinchakraborty1@gmail.com>
Date: Wed, Jun 15, 2011 at 9:13 PM
Subject: Fwd: FW: Blood Cancer
To: Rabin Chakraborty <rabinchakraborty1@gmail.com>
Here is some additional information in this connection:
1. It is to note that like other medicines this is not without side effects as reported in a communication:
Imatinib is a drug used treat certain types of cancer. Imatinib works by overcrowding an abnormal enzyme feature of the disease. Imatinib is the first accepted drug to directly turn off the signal of a protein well-known to cause a cancer. Imatinib is swiftly engrossed when given by mouth, as well as is highly bioavailable: 98% of an oral dose reach the bloodstream. Metabolism of imatinib occur in the liver .Though the long-term side effects of imatinib contain not yet been ascertain, research suggests that it is usually very in good health tolerated. Broadly, side effects such at the same time as edema, nausea, rash and musculoskeletal pain are general but soft.Hhardly ever it has been associated by means of damage to heart muscles.
2. A report in another blog:
Detailed Analysis
According to this message, India's Adyar Cancer Institute is distributing, free of charge, a medicine named 'Imitinef Mercilet' that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.
-rc
From: Rabin Chakraborty <rabinchakraborty1@gmail.com>
Date: Wed, Jun 15, 2011 at 9:13 PM
Subject: Fwd: FW: Blood Cancer
To: Rabin Chakraborty <rabinchakraborty1@gmail.com>
Here is some additional information in this connection:
1. It is to note that like other medicines this is not without side effects as reported in a communication:
Imatinib is a drug used treat certain types of cancer. Imatinib works by overcrowding an abnormal enzyme feature of the disease. Imatinib is the first accepted drug to directly turn off the signal of a protein well-known to cause a cancer. Imatinib is swiftly engrossed when given by mouth, as well as is highly bioavailable: 98% of an oral dose reach the bloodstream. Metabolism of imatinib occur in the liver .Though the long-term side effects of imatinib contain not yet been ascertain, research suggests that it is usually very in good health tolerated. Broadly, side effects such at the same time as edema, nausea, rash and musculoskeletal pain are general but soft.Hhardly ever it has been associated by means of damage to heart muscles.
2. A report in another blog:
Detailed Analysis
According to this message, India's Adyar Cancer Institute is distributing, free of charge, a medicine named 'Imitinef Mercilet' that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.'Imitinef Mercilet' is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a "Gleevec", has proved to be an effective treatment for some forms of cancers. However, "blood cancer" is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.
-rc
---------- Forwarded message ----------
From: manas joardar <manasjoardar@hotmail.com>
Date: Sat, Jun 11, 2011 at 10:33 PM
Subject: FW: Blood Cancer
From: manas joardar <manasjoardar@hotmail.com>
Date: Sat, Jun 11, 2011 at 10:33 PM
Subject: FW: Blood Cancer
To:
|
--
sadhan roy chowdhury
--
Palash Biswas
Pl Read:
http://nandigramunited-banga.blogspot.com/
Posts
No comments:
Post a Comment